Immunome (NASDAQ: IMNM) awards options and RSUs to chief legal officer
Rhea-AI Filing Summary
Immunome Inc. reported equity awards to its Chief Legal Officer and General Counsel, Sandra G. Stoneman. On July 23, 2026 she received stock options for 76,500 shares at a $22.01 exercise price, expiring July 22, 2036, plus 38,250 RSUs. The RSUs vest 25% annually on each grant-date anniversary, and the options vest 25% on July 23, 2027 with the balance vesting monthly over three years, in each case subject to continued service. Following the RSU award she directly holds 43,805 shares or RSUs of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 38,250 shares
Net Buy
2 txns
Insider
Stoneman Sandra G.
Role
CHIEF LEGAL OFFICER & GC
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F2 | 76,500 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 38,250 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 76,500 shares (Direct);
Common Stock — 43,805 shares (Direct)
Footnotes (2)
- F1. Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date.
- F2. 25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Key Figures
Stock options granted: 76,500 shares
Option exercise price: $22.01 per share
RSUs granted: 38,250 units
+4 more
7 metrics
Stock options granted
76,500 shares
Employee stock option grant to Chief Legal Officer on July 23, 2026
Option exercise price
$22.01 per share
Exercise price for options expiring July 22, 2036
RSUs granted
38,250 units
Restricted stock units representing common shares granted July 23, 2026
Post-award common stock holdings
43,805 shares
Direct common stock/RSU holdings after RSU grant
Option expiration date
July 22, 2036
Expiration of Employee Stock Option award
Initial option vesting portion
25%
Options vesting on July 23, 2027, subject to continuous service
Annual RSU vesting portion
25%
RSUs vesting each year on the anniversary of the grant date
Key Terms
restricted stock units ("RSUs"), contingent right to receive, continuous service
3 terms
restricted stock units ("RSUs") financial
"underlying restricted stock units ("RSUs"). Each RSU represents the contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
contingent right to receive financial
"Each RSU represents the contingent right to receive one share of Common Stock"
continuous service financial
"subject to the Reporting Person's continuous service through each such vesting date"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Immunome (IMNM) grant to Sandra G. Stoneman?
Immunome granted Sandra G. Stoneman 76,500 stock options and 38,250 RSUs on July 23, 2026. The options have a $22.01 exercise price, while each RSU represents the contingent right to receive one share of common stock upon settlement.
What are the vesting terms of Sandra G. Stoneman’s new RSUs at Immunome (IMNM)?
Stoneman’s 38,250 RSUs vest and settle 25% each year on the anniversary of the grant date. Vesting is conditioned on her continuous service with Immunome through each applicable vesting date.
How do Sandra G. Stoneman’s Immunome (IMNM) stock options vest and when do they expire?
Her 76,500 stock options vest 25% on July 23, 2027, with one‑thirty‑sixth of the remaining options vesting monthly thereafter. These options carry a $22.01 exercise price and expire on July 22, 2036, subject to continued service.
Are Sandra G. Stoneman’s new Immunome (IMNM) awards linked to continued employment?
Yes. Vesting of both the 38,250 RSUs and the 76,500 stock options is subject to her continuous service. If her service ends before future vesting dates, unvested portions of these awards may not vest.